Evidence map›Paper›PMID 42846742›Full record

ArticleMachine learning. Health2026

Utilizing categorical boosting and SHAP to understand key predictors of frequency of use at discharge for completed substance abuse treatments in TEDS-D.

C Flynn, S Abad, B Wooton, C Jansen, B Johnson, B Harrison, J Nash, A J Stokes, H Turner

Abstract read
In one paragraph

Article in Machine learning. Health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

C FlynnLaboratory of Pharmacology and Analytics, School of Natural Sciences and Mathematics, Chaminade University, Honolulu, Hawai'i, United States of America.ORCID https://orcid.org/0009-0004-8407-7124
S AbadScHARe Fellows Program, NIH AIM-AHEAD Consortium, Fort Worth, Texas, United States of America.ORCID https://orcid.org/0009-0009-6013-9147
B WootonLaboratory of Pharmacology and Analytics, School of Natural Sciences and Mathematics, Chaminade University, Honolulu, Hawai'i, United States of America.ORCID https://orcid.org/0009-0003-9787-2664
C JansenLaboratory of Pharmacology and Analytics, School of Natural Sciences and Mathematics, Chaminade University, Honolulu, Hawai'i, United States of America.ORCID https://orcid.org/0000-0002-1579-8938
B JohnsonLaboratory of Pharmacology and Analytics, School of Natural Sciences and Mathematics, Chaminade University, Honolulu, Hawai'i, United States of America.
B HarrisonHabilitat, Inc., Kaneohe, Hawai'i, United States of America.
J NashHabilitat, Inc., Kaneohe, Hawai'i, United States of America.
A J StokesNSF INCLUDES ALL-SPICE Alliance program, Chaminade University, Honolulu, Hawai'i, United States of America.ORCID https://orcid.org/0000-0002-3526-4685
H TurnerLaboratory of Pharmacology and Analytics, School of Natural Sciences and Mathematics, Chaminade University, Honolulu, Hawai'i, United States of America.ORCID https://orcid.org/0000-0002-9629-7691

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AI/MLhealthcare analyticssubstance abuseTEDS-Dtreatment outcomes

Identifiers

PMID42846742
PMCPMC13643250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.